{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:09:27Z","timestamp":1776078567478,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013091","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000}}],"reference-count":111,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013091.pub2","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T01:46:57Z","timestamp":1635212817000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review"],"prefix":"10.1002","volume":"2021","author":[{"given":"Emma C","family":"Atakpa","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health; Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mangesh A","family":"Thorat","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health; Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London UK"},{"name":"School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine; King's College London; London UK"},{"name":"Breast Services, Guy\u2019s Hospital; Guy's and St Thomas' NHS Foundation Trust; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Cuzick","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health; Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam R","family":"Brentnall","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health; Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD013091.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/jnci\/djr079","article-title":"Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study","volume":"103","author":"Cuzick","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10.1002\/14651858.CD013091.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/bcr3221","article-title":"Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer","volume":"14","author":"Kim","year":"2012","journal-title":"Breast Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD013091.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13058-018-0948-4","article-title":"The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study","volume":"20","author":"Knight","year":"2018","journal-title":"Breast Cancer Research"},{"issue":"3","key":"10.1002\/14651858.CD013091.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10549-013-2726-4","article-title":"Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients","volume":"142","author":"Ko","year":"2013","journal-title":"Breast Cancer Research and Treatment"},{"issue":"18","key":"10.1002\/14651858.CD013091.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1200\/JCO.2012.44.5015","article-title":"Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer","volume":"31","author":"Li","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD013091.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"dju425","DOI":"10.1093\/jnci\/dju425","article-title":"Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer","volume":"107","author":"Nyante","year":"2015","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10.1002\/14651858.CD013091.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/bcr3451","article-title":"Change of mammographic density predicts the risk of contralateral breast cancer - a case-control study","volume":"15","author":"Sandberg","year":"2013","journal-title":"Breast Cancer Research"},{"issue":"3","key":"10.1002\/14651858.CD013091.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/0284186X.2014.964809","article-title":"Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: a Dutch TEAM trial analysis","volume":"54","author":"Nes","year":"2015","journal-title":"Acta Oncologica"},{"issue":"9","key":"10.1002\/14651858.CD013091.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/aje\/kwx178","article-title":"Mammographic density reduction as a prognostic marker for postmenopausal breast cancer: results using a joint longitudinal-survival modelling approach","volume":"186","author":"Andersson","year":"2017","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0010|cit10","first-page":"863-6","article-title":"Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen","volume":"8","author":"Atkinson","year":"1999","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-3-540-69297-3_14","article-title":"Exogenous and endogenous hormones, mammographic density and breast cancer risk: can mammographic density be considered an intermediate marker of risk?","volume":"181","author":"Becker","year":"2009","journal-title":"Recent Results in Cancer Research"},{"issue":"9","key":"10.1002\/14651858.CD013091.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0221-0363(08)73930-1","article-title":"Hormones and mammographic breast density","volume":"89","author":"Boisserie-Lacroix","year":"2008","journal-title":"Journal de Radiologie"},{"issue":"10 Pt 1","key":"10.1002\/14651858.CD013091.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0221-0363(04)97731-1","article-title":"Menopausal hormonal therapies: impact on mammographic breast density","volume":"85","author":"Boutet","year":"2004","journal-title":"Journal de Radiologie"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"314-21","DOI":"10.1007\/s11912-001-0083-7","article-title":"Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention","volume":"3","author":"Boyd","year":"2001","journal-title":"Current Oncology Reports"},{"issue":"9","key":"10.1002\/14651858.CD013091.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/djr115","article-title":"Tamoxifen, mammographic density, and breast cancer prevention","volume":"103","author":"Boyd","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1002\/14651858.CD013091.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnci\/95.1.4","article-title":"Biological significance of interventions that change breast density","volume":"95","author":"Chlebowski","year":"2003","journal-title":"Journal of the National Cancer Institute"},{"issue":"Suppl","key":"10.1002\/14651858.CD013091.pub2-BIB0017|cit17","first-page":"245","article-title":"Chemoprevention of breast cancer by using tamoxifen: radiologic evaluation","volume":"189","author":"Cosmacini","year":"1993","journal-title":"Radiology"},{"issue":"4","key":"10.1002\/14651858.CD013091.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/bcr3235","article-title":"Breast density predicts endocrine treatment outcome in the adjuvant setting","volume":"14","author":"Cuzick","year":"2012","journal-title":"Breast Cancer Research"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0019|cit19","doi-asserted-by":"crossref","unstructured":"Decensi A Bonanni B Guerrieri GA Robertson C Cazzaniga M Mariette F A randomized 2x2 biomarker trial of low-dose tamoxifen and fenretinide in postmenopausal women at high-risk for breast cancer American Society of Clinical Oncology Annual Meeting; 2004 June 5-8; New Orleans Baltimore Lippincott Williams & Wilkins 2004 97","DOI":"10.1200\/jco.2004.22.90140.1001"},{"issue":"23","key":"10.1002\/14651858.CD013091.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1200\/JCO.2008.19.3797","article-title":"Randomized double-blind 2x2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women","volume":"27","author":"Decensi","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013091.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"127-44","DOI":"10.1177\/1534735416628343","article-title":"Relationship between breast density and selective estrogen-receptor modulators, aromatase inhibitors, physical activity, and diet: a systematic review","volume":"15","author":"Ekpo","year":"2016","journal-title":"Integrative Cancer Therapies"},{"issue":"6","key":"10.1002\/14651858.CD013091.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/1055-9965.EPI-16-0882","article-title":"Longitudinal changes in volumetric breast density with tamoxifen and aromatase inhibitors","volume":"26","author":"Engmann","year":"2017","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"4","key":"10.1002\/14651858.CD013091.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"pky071","DOI":"10.1093\/jncics\/pky071","article-title":"Adjuvant therapy and mammographic density changes in women with breast cancer","volume":"2","author":"Eriksson","year":"2018","journal-title":"JNCI Cancer Spectrum"},{"issue":"10","key":"10.1002\/14651858.CD013091.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2705S","DOI":"10.1093\/jn\/136.10.2705S","article-title":"Mammographic density: use in risk assessment and as a biomarker in prevention trials","volume":"136","author":"Fabian","year":"2006","journal-title":"Journal of Nutrition"},{"issue":"1-5","key":"10.1002\/14651858.CD013091.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsbmb.2007.05.022","article-title":"Use of biomarkers for breast cancer risk assessment and prevention","volume":"106","author":"Fabian","year":"2007","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-319-22909-6_3","article-title":"Incorporating biomarkers in studies of chemoprevention","volume":"882","author":"Fabian","year":"2016","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"10.1002\/14651858.CD013091.pub2-BIB0027|cit27","first-page":"34","article-title":"Mammographic breast density, endocrine therapies, and breast cancer risk","volume":"8","author":"Ghosh","year":"2010","journal-title":"Sexuality, Reproduction and Menopause"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.breast.2019.07.002","article-title":"Are mammographic density phenotypes associated with breast cancer treatment response and clinical outcomes? A systematic review and meta-analysis","volume":"47","author":"Kanbayti","year":"2019","journal-title":"Breast"},{"issue":"4","key":"10.1002\/14651858.CD013091.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2214\/AJR.13.11109","article-title":"Smaller reduction in 3D breast density associated with subsequent cancer recurrence in patients with breast cancer receiving adjuvant tamoxifen therapy","volume":"202","author":"Kim","year":"2014","journal-title":"American Journal of Roentgenology"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"f2645","DOI":"10.1136\/bmj.f2645","article-title":"Breast density on mammography can help assess response to tamoxifen and predict survival, finds study","volume":"346","author":"Kmietowicz","year":"2013","journal-title":"BMJ"},{"key":"#cr-split#-10.1002\/14651858.CD013091.pub2-BIB0031|cit31.1","unstructured":"Cancer Research 2011 Abstract number 3671"},{"key":"#cr-split#-10.1002\/14651858.CD013091.pub2-BIB0031|cit31.2","doi-asserted-by":"crossref","unstructured":"Macis D Gandini S Guerrieri-Gonzaga A Harriet J Serrano D Cazzaniga M Associations between a polymorphic locus in the promoter region of the IGFBP-3 gene, circulating IGFs, mammographic breast density and survival in a 2x2 trial of low-dose tamoxifen and fenretinide in premenopausal women 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando","DOI":"10.1158\/1538-7445.AM2011-3671"},{"key":"#cr-split#-10.1002\/14651858.CD013091.pub2-BIB0031|cit31.3","unstructured":"(FL) Philadelphia AACR; Cancer Research 2011 Abstract number 3671"},{"issue":"1","key":"10.1002\/14651858.CD013091.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.maturitas.2009.07.009","article-title":"Hormone therapy, mammographic density, and breast cancer risk","volume":"64","author":"Martin","year":"2009","journal-title":"Maturitas"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD013091.pub2-BIB0033|cit33","first-page":"72","article-title":"Mammographic breast-density change as a predictor of outcome in hormone receptor positive breast cancer","volume":"12","author":"Martin","year":"2016","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"issue":"18","key":"10.1002\/14651858.CD013091.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2093-7","DOI":"10.1200\/JCO.2015.64.4492","article-title":"Mammographic density as a biosensor of tamoxifen effectiveness in adjuvant endocrine treatment of breast cancer: opportunities and implications","volume":"34","author":"Mullooly","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD013091.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"pky072","DOI":"10.1093\/jncics\/pky072","article-title":"The potential for mammographic breast density change as a biosensor of adjuvant tamoxifen therapy adherence and response","volume":"2","author":"Mullooly","year":"2018","journal-title":"JNCI Cancer Spectrum"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3390\/jcm8111868","article-title":"Involution of breast lobules, mammographic breast density and prognosis among tamoxifen-treated estrogen receptor-positive breast cancer patients","volume":"8","author":"Mullooly","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0037|cit37","unstructured":"Exemestane in reducing breast density in postmenopausal women at risk for breast cancer clinicaltrials.gov\/ct2\/show\/NCT00066586"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0038|cit38","unstructured":"Effect of tamoxifen on breast density in premenopausal women with breast cancer or high risk for breast cancer clinicaltrials.gov\/ct2\/show\/NCT00086749"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0039|cit39","unstructured":"Letrozole with or without zoledronate in treating healthy postmenopausal women with high breast density clinicaltrials.gov\/ct2\/show\/NCT00114270"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0040|cit40","unstructured":"Letrozole in preventing breast cancer in postmenopausal women who are at increased risk for breast cancer due to high breast density clinicaltrials.gov\/ct2\/show\/NCT00238316"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0041|cit41","unstructured":"Breast density, hormone levels, and anticancer drug levels in women with invasive breast cancer who are receiving exemestane or anastrozole clinicaltrials.gov\/ct2\/show\/NCT00316836"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0042|cit42","unstructured":"Changes in breast density and breast cancer risk in women with breast cancer and in healthy women clinicaltrials.gov\/ct2\/show\/NCT00445445"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0043|cit43","unstructured":"Changes in breast density and blood hormone levels in postmenopausal women receiving anastrozole or exemestane for breast cancer clinicaltrials.gov\/ct2\/show\/NCT00516698"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0044|cit44","unstructured":"Breast density change predicting response to adjuvant aromatase inhibitor (DEAR) clinicaltrials.gov\/ct2\/show\/NCT01765049"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0045|cit45","unstructured":"Development of a quantitative tissue optical index of breast density for prediction of hormone therapy response clinicaltrials.gov\/ct2\/show\/NCT01773551"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0046|cit46","doi-asserted-by":"crossref","unstructured":"Ozhand A McKean-Cowdin R Bernstein L Ballard-Babash R McTiernan A Baumgartner KB Short term reduction in mammographic density predicts survival in breast cancer 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC Philadelphia AACR; Cancer Research 2013 Abstract number 2286","DOI":"10.1158\/1538-7445.AM2013-2286"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD013091.pub2-BIB0047|cit47","first-page":"100","article-title":"Breast density change: toward tailoring of adjuvant endocrine therapy","volume":"12","author":"Redfern","year":"2016","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"key":"#cr-split#-10.1002\/14651858.CD013091.pub2-BIB0048|cit48.1","unstructured":"Cancer Research 2016 Abstract number PD1 06"},{"key":"#cr-split#-10.1002\/14651858.CD013091.pub2-BIB0048|cit48.2","unstructured":"Redfern AD Martin HL Stone J Davidson JA Yap F Chung K Mammographic breast density as a predictor of hormone receptor positive breast cancer recurrence: a single centre longitudinal analysis 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; 2015 Dec 8-12; San Antonio"},{"key":"#cr-split#-10.1002\/14651858.CD013091.pub2-BIB0048|cit48.3","unstructured":"(TX) Philadelphia AACR; Cancer Research 2016 Abstract number PD1 06"},{"issue":"3","key":"10.1002\/14651858.CD013091.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.18632\/oncotarget.13484","article-title":"Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies","volume":"8","author":"Shawky","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1002\/14651858.CD013091.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jnci\/88.2.128-a","article-title":"Can mammographic densities predict effects of tamoxifen on the breast?","volume":"88","author":"Ursin","year":"1996","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1002\/14651858.CD013091.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12609-013-0118-8","article-title":"Mammographic density: potential as a risk factor and surrogate marker in the clinical setting","volume":"5","author":"Vachon","year":"2013","journal-title":"Current Breast Cancer Reports"},{"issue":"8","key":"10.1002\/14651858.CD013091.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1158\/1078-0432.CCR-12-2789","article-title":"Mammographic breast density response to aromatase inhibition","volume":"19","author":"Vachon","year":"2013","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.1002\/14651858.CD013091.pub2-BIB0053|cit53","first-page":"70","article-title":"Mammographic changes by endocrine therapy","volume":"3","author":"Whitman","year":"2000","journal-title":"Seminars in Breast Disease"},{"issue":"1-3","key":"10.1002\/14651858.CD013091.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1006193704132","article-title":"Methodological challenges in the evaluation of prognostic factors in breast cancer","volume":"52","author":"Altman","year":"1998","journal-title":"Breast Cancer Research and Treatment"},{"issue":"7306","key":"10.1002\/14651858.CD013091.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bmj.323.7306.224","article-title":"Systematic reviews in health care: systematic reviews of evaluations of prognostic variables","volume":"323","author":"Altman","year":"2001","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD013091.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"e1001216","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration","volume":"9","author":"Altman","year":"2012","journal-title":"PLOS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013091.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrclinonc.2011.173","article-title":"Clinical and epidemiological issues in mammographic density","volume":"9","author":"Assi","year":"2011","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD013091.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Statistical Methods in Medical Research"},{"issue":"12","key":"10.1002\/14651858.CD013091.pub2-BIB0059|cit59","first-page":"1133","article-title":"Mammographic densities and breast cancer risk","volume":"7","author":"Boyd","year":"1998","journal-title":"Cancer Epidemiology and Prevention Biomarkers"},{"issue":"5","key":"10.1002\/14651858.CD013091.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1158\/1055-9965.EPI-05-0762","article-title":"Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer","volume":"15","author":"Boyd","year":"2006","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"10","key":"10.1002\/14651858.CD013091.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1088\/0031-9155\/39\/10\/008","article-title":"The quantitative analysis of mammographic densities","volume":"39","author":"Byng","year":"1994","journal-title":"Physics in Medicine and Biology"},{"issue":"9","key":"10.1002\/14651858.CD013091.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djx001","article-title":"Mammographic density change with estrogen and progestin therapy and breast cancer risk","volume":"109","author":"Byrne","year":"2017","journal-title":"Journal of the National Cancer Institute"},{"issue":"10204","key":"10.1002\/14651858.CD013091.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","author":"Collaborative Group on Hormonal Factors in Breast Cancer (CGHFBC)","year":"2019","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0064|cit64","unstructured":"Veritas Health Innovation Covidence"},{"issue":"8","key":"10.1002\/14651858.CD013091.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jnci\/djh106","article-title":"Tamoxifen and breast density in women at increased risk of breast cancer","volume":"96","author":"Cuzick","year":"2004","journal-title":"Journal of the National Cancer Institute"},{"issue":"32","key":"10.1002\/14651858.CD013091.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1200\/JCO.2010.31.2835","article-title":"Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer","volume":"29","author":"Cuzick","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"9880","key":"10.1002\/14651858.CD013091.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","article-title":"Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data","volume":"381","author":"Cuzick","year":"2013","journal-title":"Lancet"},{"issue":"9922","key":"10.1002\/14651858.CD013091.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD013091.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(14)71171-4","article-title":"Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial","volume":"16","author":"Cuzick","year":"2015","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0070|cit70","volume-title":"ACR BI-RADS Atlas: Breast Imaging Reporting and Data System","author":"D'Orsi","year":"2013"},{"issue":"9793","key":"10.1002\/14651858.CD013091.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet"},{"issue":"9114","key":"10.1002\/14651858.CD013091.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials","volume":"351","author":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG)","year":"1998","journal-title":"Lancet"},{"issue":"10001","key":"10.1002\/14651858.CD013091.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","author":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG)","year":"2015","journal-title":"Lancet"},{"issue":"7109","key":"10.1002\/14651858.CD013091.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0075|cit75","unstructured":"Ferlay J Soerjomataram I Ervik M Dikshit R Eser S Mathers C GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 globocan.iarc.fr"},{"issue":"24","key":"10.1002\/14651858.CD013091.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0077|cit77","unstructured":"Google Scholar scholar.google.com"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0078|cit78","unstructured":"Google Translate translate.google.com"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"2381-91","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0080|cit80","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"issue":"2","key":"10.1002\/14651858.CD013091.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0720-048X(96)01138-2","article-title":"The Tab\u00e1r classification of mammographic parenchymal patterns","volume":"24","author":"Gram","year":"1997","journal-title":"European Journal of Radiology"},{"issue":"33","key":"10.1002\/14651858.CD013091.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","article-title":"American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer","volume":"25","author":"Harris","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"21","key":"10.1002\/14651858.CD013091.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/jnci\/89.21.1623","article-title":"Short-term cessation of hormone replacement therapy and improvement of mammographic specificity","volume":"89","author":"Harvey","year":"1997","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"10.1002\/14651858.CD013091.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","article-title":"Evaluation of the quality of prognosis studies in systematic reviews","volume":"144","author":"Hayden","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013091.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/978-3-642-13666-5_46","volume-title":"Digital Mammography","volume":"6136","author":"Highnam","year":"2010"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"e5793","DOI":"10.1136\/bmj.e5793","article-title":"Prognosis research strategy (PROGRESS) 4: Stratified medicine research","volume":"346","author":"Hingorani","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD013091.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-014-2901-2","article-title":"Mammographic density - a review on the current understanding of its association with breast cancer","volume":"144","author":"Huo","year":"2014","journal-title":"Breast Cancer Research and Treatment"},{"issue":"13","key":"10.1002\/14651858.CD013091.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.steroids.2007.07.009","article-title":"New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer","volume":"72","author":"Jordan","year":"2007","journal-title":"Steroids"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsbmb.2014.03.003","article-title":"An overview of current and emerging SERMs","volume":"143","author":"Komm","year":"2014","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD013091.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","article-title":"Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis","volume":"15","author":"McCormack","year":"2006","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"36","key":"10.1002\/14651858.CD013091.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","article-title":"Reporting recommendations for tumor marker prognostic studies","volume":"23","author":"McShane","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"18","key":"10.1002\/14651858.CD013091.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/dji279","article-title":"Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial","volume":"97","author":"McTiernan","year":"2005","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0095|cit95","unstructured":"National Center for Biotechnology Information PubMed pubmed.ncbi.nlm.nih.gov"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0096|cit96","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2020"},{"issue":"8","key":"10.1002\/14651858.CD013091.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/sj.bjc.6604999","article-title":"Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis and beyond","volume":"100","author":"Riley","year":"2009","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD013091.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"e1001380","DOI":"10.1371\/journal.pmed.1001380","article-title":"Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research","volume":"10","author":"Riley","year":"2013","journal-title":"PLOS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013091.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.285.2.171","article-title":"Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy","volume":"285","author":"Rutter","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0100|cit100","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glaziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0101|cit101","unstructured":"Sch\u00fcnemann H Brozek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD013091.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD013091.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-148-5-200803040-00004","article-title":"Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model","volume":"148","author":"Tice","year":"2008","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD013091.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"23","key":"10.1002\/14651858.CD013091.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","article-title":"Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Visvanathan","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD013091.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2214\/ajr.126.6.1130","article-title":"Breast patterns as an index of risk for developing breast cancer","volume":"126","author":"Wolfe","year":"1976","journal-title":"American Journal of Roentgenology"},{"issue":"8","key":"10.1002\/14651858.CD013091.pub2-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013091","article-title":"Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review","author":"Atakpa","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T16:01:52Z","timestamp":1673366512000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013091.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Breast Cancer Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":111,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013091.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]}}}